Matrix Capital Management Company, LP - 30 Sep 2025 SCHEDULE 13G/A Report for Maze Therapeutics, Inc. Common Stock, par value $0.001 per share (MAZE)

Filing Manager
Matrix Capital Management Company, LP
Reporting Manager
Matrix Capital Management Company, LP
Security
Maze Therapeutics, Inc. Common Stock, par value $0.001 per share
Symbol
MAZE
Shares outstanding
47,248,114 shares
Disclosed Ownership
1,653,684 shares
Ownership
3.5%
Form type
SCHEDULE 13G/A
Filing time
13 Nov 2025, 16:10:25 UTC
Date of event
30 Sep 2025
Previous filing
14 May 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"Matrix Capital Management Company, LP disclosed 3.5% ownership in Maze Therapeutics, Inc. Common Stock, par value $0.001 per share (MAZE) on 30 Sep 2025."

Quick Takeaways

  • Matrix Capital Management Company, LP filed SCHEDULE 13G/A for Maze Therapeutics, Inc. Common Stock, par value $0.001 per share (MAZE).
  • Disclosed ownership: 3.5%.
  • Date of event: 30 Sep 2025.

What Changed

  • Previous schedule filing date: 14 May 2025.
  • Current filing was accepted on 13 Nov 2025, 16:10.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Matrix Capital Management Company, LP 3.5% 1,653,684 0 1,653,684 /s/ David E. Goel David E. Goel, Managing General Partner
DAVID E. GOEL 3.5% 1,653,684 0 1,653,684 /s/ David E. Goel David E. Goel, individually

Sponsored